US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NASDAQ
Arcutis Biotherapeutics Inc (ARQT)
Arcutis Biotherapeutics Inc (ARQT) ニュース

Arcutis Biotherapeutics Inc (ARQT)

27.285

1.22

( 4.66% )

更新日時： 03:18:26

個人投資家向けのプロ仕様のツール。

プレミアム

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WESTLAKE VILLAGE, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a...

Arcutis Launches New Virtual Health Platform Supporting Access to Care for Individuals Living with Chronic Inflammatory Skin Diseases, Including Approved ZORYVE® (roflumilast) Indications

Virtual health platform offers an additional pathway to care for the more than 45 million people in the U.S...

FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2

ZORYVE cream 0.3% is the first once-daily, non-steroidal therapy approved for children with plaque psoriasis as...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WESTLAKE VILLAGE, Calif., June 05, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a...

New Expert Consensus Provides Age-Specific Guidance for Improving Care for Individuals with Genital Psoriasis Published in the American Journal of Clinical Dermatology

Expert recommendations focused on the diagnosis and management of genital psoriasis across age groups including...

Arcutis Management to Present at Goldman Sachs 47th Annual Global Healthcare Conference

WESTLAKE VILLAGE, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a...

52172

Check next stop 32

52172

Where are we headed? 30's?

BottomBounce

BottomBounce 1年前

It’s insane how things that were common knowledge just decades ago get memory-holed like this.

They want us to forget. pic.twitter.com/NBCdjY6yNH— Died Suddenly (@DiedSuddenly_) May 9, 2025 $ARQT

52172

Keep marching 20's imminent

Monksdream

Monksdream 2年前

52172

Ath’s incoming

52172

Put the crackpipe down

52172

Wrong we beat big time sucka

52172

Sierra20

Sierra20 2年前

Sierra20

Sierra20 2年前

Earnings missed big time and this tanks hard

52172

Not yet need 20’s which will come

MiamiGent

MiamiGent 2年前

ARQT $10.82 HOD!
Everybody happy?

52172

Some large transactions happening a sign of whats to come

52172

Gonna close green watch

MiamiGent

MiamiGent 2年前

ARQT The short interest is about 25%
The free trading float is tiny.
Share Price should rise steadily today.

MiamiGent

MiamiGent 2年前

ARQT $10.69 last pre-mkt buy, up .67 from yesterday's close.
Steadily rising, as I expected.

The mkt for this FDA approved medicine (last night) is reportedly multi- billions of dollars.

52172

MiamiGent

MiamiGent 2年前

ARQT Needham Reiterates BUY on Arcutis Biotherapeutics, maintains $18 Price Target

6:28 AM this morning

MiamiGent

MiamiGent 2年前

ARQT That's right. The market for this is reportedly three times larger than the previous approved candidate- and that one grew about 250% last qtr.
AND, Arcutis (ARQT) will roll out this new medicine by the end of THIS MONTH.

I am going to buy this product- I have psoriasis all over, except my face thank God.

52172

Real revenue is gonna begin to come in.

52172

Headed to 20’s soon enough!

MiamiGent

MiamiGent 2年前

$ARQT HUge short interest, next to no free float and FDA Approval tonight for a BIG MARKET drug.
The boys will run this tomorrow.

MiamiGent

MiamiGent 2年前

$ARQT
Arcutis Biotherapeutics Inc

My guess it'll be $11 by 8PM.
The real fun starts in Pre-Market, tomorrow, And then I think off to the races in Regular Session.
Bullish

MiamiGent

MiamiGent 2年前

$ARQT Tight Bid and ASK now.
Getting serious.
Bid ARCX
10.55 x 10
Ask XNMS
10.59 x 1
Volume
2,437,578
Bullish

MiamiGent

MiamiGent 2年前

$ARQT
Arcutis Biotherapeutics Inc

I told ya!
Currently in AH
Bid XNMS 10.50 x 13
Ask ARCX 10.67 x 20
Volume
2,429,849
Bullish

MiamiGent

MiamiGent 2年前

$ARQT New traders: Look at those big $10.48 buys!
The few that follow are "paint jobs"- shorts trying to paint weakness.
Pay attention to the big buys!
$ARQT
18:07:49 $10.41 5 paint job
18:07:49 $10.35 20 paint job
18:07:45 $10.48 15 paint job
18:07:25 $10.48 7,900 real buy
18:07:25 $10.48 1,500 real buy
18:07:01 $10.3567 30
18:05:44 $10.49 115
18:04:57 $10.49 9,400
18:04:26 $10.4887 110
18:03:38 $10.42 6,212
18:03:38 $10.42 2,200
Bullish

MiamiGent

MiamiGent 2年前

ARQT Arcutis Biotherapeutics' Zoryve Gets US FDA Approval!

Sierra20

Sierra20 2年前

I hope it will be approved. I think it will be approved. It’s just weird.

MiamiGent

MiamiGent 2年前

You're being unnecessarily doomsdayish, Sierra.

Fact is FDA has not announced re any candidates since July 3rd. There's an American holiday on the 4th (Thursday) and folks often take the next day off to make it a four-day break with only one vacation day used.
Hope the weather is not as hot in Albania or wherever it is you plot your short plays and bashing.
MG

Sierra20

Sierra20 2年前

CRL more than likely. I knew it. F! This is horrible!!!!
https://investors.arcutis.com/news-releases/news-release-details/arcutis-provides-update-snda-roflumilast-cream-015-atopic/

Sierra20

Sierra20 2年前

They got CRL. 😔
There’s no other reason for this delay. Back to $5 I think.

Sierra20

Sierra20 2年前

I think they are talking to fda to figure out what they needed to do to address the fda’s concerns before giving a pr about CRL.

MiamiGent

MiamiGent 2年前

ARQT Only 40 more minutes for FDA to announce today.
One time it did at 11:30 PM and it was a QUADRUPLE!

MiamiGent

MiamiGent 2年前

You must be short. There's no basis for what you are saying.

MiamiGent

MiamiGent 2年前

AQRT I'm in today.

Sierra20

Sierra20 2年前

CRL coming at 4 pm est. imo.

Sierra20

Sierra20 2年前

I think CRL coming…

Sierra20

Sierra20 2年前

52172

Havent missed nothing yet!

52172

Sierra20

Sierra20 2年前

I have the worst luck. I miss all the PDUFA. If they get delayed should not be a problem.

Sierra20

Sierra20 2年前

Sierra20

Sierra20 2年前

CRL? Delayed? What’s going on?

Monksdream

Monksdream 2年前

52172

No one knows shit approval is imminent

Sierra20

Sierra20 2年前

Someone knows something sell off started. 😔

Sierra20

Sierra20 2年前

I hope they didn’t get a CRL. People are selling. Something is going on.

52172

408k share buy ah’s nothing else needed to say!

52172

20’s imminent mark this post

Arcutis Biotherapeutics

Arkle Master Issuer

Invesco S&p 500 Qvm Ucit...

Mirum Pharmaceuticals

Ramsay Healthcare

Bmo Global Innovators Fu...

Aim Exploration (EM)

Bmo Selecttrust Balanced...

Citibank Na Point to Poi...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。